Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey R Jaglowski

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Cancer Letters|January 18, 2006
Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of fusaric acid and paclitaxel or carboplatinJeffrey R Jaglowski, Brendan C Stack
Archives of Neurology|March 10, 2010
Spinal epidural metastasisBrian P Walcott, Jeffrey R Jaglowski, William T Curry
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|November 9, 2014
High-load preconditioning of soft tissue grafts: an in vitro biomechanical bovine tendon modelJeffrey R Jaglowski, Brady T Williams, Travis Lee Turnbull, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|February 27, 2015
Lack of consensus regarding pretensioning and preconditioning protocols for soft tissue graft reconstruction of the anterior cruciate ligamentKyle A Jisa, Brady T Williams, Jeffrey R Jaglowski, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinomaIan S Zagon, Jeffrey R Jaglowski, Michael F Verderame, et al.
International Journal of Oncology|February 11, 2005
Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factorPatricia J McLaughlin, Jeffrey R Jaglowski, Michael F Verderame, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2005
Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neckJeffrey R Jaglowski, Ian S Zagon, Brendan C Stack, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Cancer Letters|January 18, 2006
Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of fusaric acid and paclitaxel or carboplatinJeffrey R Jaglowski, Brendan C Stack
Archives of Neurology|March 10, 2010
Spinal epidural metastasisBrian P Walcott, Jeffrey R Jaglowski, William T Curry
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|November 9, 2014
High-load preconditioning of soft tissue grafts: an in vitro biomechanical bovine tendon modelJeffrey R Jaglowski, Brady T Williams, Travis Lee Turnbull, et al.
Knee Surgery, Sports Traumatology, Arthroscopy : Official Journal of the ESSKA|February 27, 2015
Lack of consensus regarding pretensioning and preconditioning protocols for soft tissue graft reconstruction of the anterior cruciate ligamentKyle A Jisa, Brady T Williams, Jeffrey R Jaglowski, et al.
Cancer Chemotherapy and Pharmacology|June 11, 2005
Combination chemotherapy with gemcitabine and biotherapy with opioid growth factor (OGF) enhances the growth inhibition of pancreatic adenocarcinomaIan S Zagon, Jeffrey R Jaglowski, Michael F Verderame, et al.
International Journal of Oncology|February 11, 2005
Enhanced growth inhibition of squamous cell carcinoma of the head and neck by combination therapy of paclitaxel and opioid growth factorPatricia J McLaughlin, Jeffrey R Jaglowski, Michael F Verderame, et al.
Cancer Chemotherapy and Pharmacology|March 26, 2005
Opioid growth factor enhances tumor growth inhibition and increases the survival of paclitaxel-treated mice with squamous cell carcinoma of the head and neckJeffrey R Jaglowski, Ian S Zagon, Brendan C Stack, et al.
Pageof 1